Purchase Order W81K0019PM031
Award Date 10/1/19
Potential Completion Date 3/31/20
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,332,143.51 definitive, firm-fixed-price federal contract awarded by the Department of the Army Medical Command to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Fisher Scientific. The contract is for the provision of allergy testing equipment, reagents, and associated consumables to support the military's medical readiness mission. Phadia has previously provided similar allergy testing products and services to other Department of Defense health agencies and...
- This is a federal contract award to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide reagents required for allergy testing. The contract is a Blanket Purchase Agreement (BPA) Call with the Defense Health Agency, a defense agency, with a ceiling value of $24,960.42 and a completion date of September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide Phadia Allergy Testing Reagents to the Tripler Army Medical Center (TAMC) in Hawaii. The $546,082.44 contract has a completion date of September 30, 2023. Phadia has previously provided allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support military medical readiness....
- The Defense Health Agency (DHA) awarded Phadia US Inc.'s Immunodiagnostics Division a $24,142.06 Blanket Purchase Agreement (BPA) call on August 16, 2025, for allergy testing reagents to be delivered to Portage, Michigan by September 30, 2025. This firm fixed-price contract represents an open market procurement with no set-aside designation. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced immunodiagnostic solutions and has established itself as a...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- This is a purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide various analyzers and reagents for Tripler Army Medical Center (TAMC) in Hawaii. The contract has a potential value of $600,075.40 and was awarded on a firm fixed price basis, with a completion date of September 30, 2020. No set-aside designation was used. Through this and past federal contracts, Phadia has provided allergy testing...
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $49,732.62 to Phadia US Inc.'s Immunodiagnostics Division on December 4, 2025, for allergy testing services that provide critical information in the detection and management of allergic reactions. The contract, which is set to be completed by September 30, 2026, will be performed in Portage, Michigan. As a subsidiary of Thermo Fisher Scientific specializing in advanced allergy and autoimmune...
- The Defense Health Agency awarded Phadia US Inc. a firm fixed-price purchase order valued at $596,483.76 for allergy testing analyzers and reagents to support the Core Laboratory at Tripler Army Medical Center in Hawaii. The contract, which was awarded on October 1, 2023, with an ultimate completion date of September 30, 2026, covers FY24 and FY26 funding and does not utilize a set-aside designation. Phadia US Inc., the Immunodiagnostics Division of Thermo Fisher Scientific, is a specialized...